UniProt Q8TCD0
8ANC195 G52K5 Fab light chain (Q8TCD0)
8ANC195 G52K5 Fab light chain (UniProt Q8TCD0): 61 experimental structures on GenesisL1, 4 ligands bound, 13 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q8TCD0
- Protein
- 8ANC195 G52K5 Fab light chain
- Experimental structures
- 61
- Predicted models
- 0
- Ligands
- 4
- Pockets
- 13 · 2 records with a druggable one
Structures
61 records of Q8TCD0 in the MolNFT archive: 61 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1HZH | Crystal structure of the intact human IgG B12 with broad and potent activity against primary HIV-1… | x-ray diffraction | L, M | — | — |
| 1HZH | Crystal structure of the intact human IgG B12 with broad and potent activity against primary HIV-1… | x-ray diffraction | L, M | — | — |
| 1N0X | Crystal Structure of a Broadly Neutralizing Anti-HIV-1 Antibody in Complex with a Peptide Mimotope | x-ray diffraction | L, M | — | — |
| 1N0X | Crystal structure of a broadly neutralizing anti-HIV-1 antibody in complex with a peptide mimotope | x-ray diffraction | L, M | — | — |
| 3CFJ | Crystal structure of catalytic elimination antibody 34E4, orthorhombic crystal form | x-ray diffraction | L, A, C, E | — | — |
| 3CFJ | Crystal structure of catalytic elimination antibody 34E4, orthorhombic crystal form | x-ray diffraction | L, A, C, E | — | — |
| 3CFK | Crystal structure of catalytic elimination antibody 34E4, triclinic crystal form | x-ray diffraction | L, A, C, E, G, J, M, O | — | — |
| 3CFK | Crystal structure of catalytic elimination antibody 34E4, triclinic crystal form | x-ray diffraction | L, A, C, E, G, J, M, O | — | — |
| 3MNV | Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment | x-ray diffraction | A, C | — | — |
| 3MNV | Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment | x-ray diffraction | A, C | — | — |
| 3MNW | Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived… | x-ray diffraction | A | — | — |
| 3MNW | Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a GP41 mper-derived… | x-ray diffraction | A | — | — |
| 3MNZ | Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived… | x-ray diffraction | A | — | — |
| 3MNZ | Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a GP41 mper-derived… | x-ray diffraction | A | — | — |
| 3PGF | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder… | x-ray diffraction | L | — | — |
| 3PGF | Crystal structure of maltose bound mbp with a conformationally specific synthetic antigen binder… | x-ray diffraction | L | — | — |
| 4D9Q | Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D | x-ray diffraction | D, L | — | — |
| 4D9Q | Inhibiting alternative pathway complement activation by targeting the exosite on factor D | x-ray diffraction | D, L | — | — |
| 4NUG | Crystal structure of HIV-1 broadly neutralizing antibody PGT151 | x-ray diffraction | L | — | — |
| 4NUG | Crystal structure of HIV-1 broadly neutralizing antibody PGT151 | x-ray diffraction | L | — | — |
| 4NUJ | Crystal structure of HIV-1 broadly neutralizing antibody PGT152 | x-ray diffraction | A | — | — |
| 4NUJ | Crystal structure of HIV-1 broadly neutralizing antibody PGT152 | x-ray diffraction | A | — | — |
| 4NWT | Crystal structure of the anti-human NGF Fab APE1531 | x-ray diffraction | L | — | — |
| 4NWT | Crystal structure of the anti-human ngf Fab APE1531 | x-ray diffraction | L | — | — |
| 4NWU | Crystal structure of APE1551, an anti-human NGF Fab with a nine amino acid insertion in CDR H1 | x-ray diffraction | L | — | — |
| 4NWU | Crystal structure of APE1551, an anti-human ngf Fab with a nine amino acid insertion in cdr H1 | x-ray diffraction | L | — | — |
| 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | electron microscopy | L, N, P | NAG, BMA, MAN | — |
| 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | electron microscopy | L, N, P | NAG, MAN | — |
| 5VJ6 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 | electron microscopy | N, P, R | — | — |
| 5VKK | Crystal structure of Fab fragment of anti-CD22 Epratuzumab | x-ray diffraction | L, B | — | 8 (best 0.71) |
| 5VKK | Crystal structure of Fab fragment of anti-CD22 epratuzumab | x-ray diffraction | L, B | — | — |
| 5VL3 | CD22 D1-D3 in complex with therapeutic Fab epratuzumab | x-ray diffraction | B, D, F, L | — | — |
| 5VOD | Crystal structure of hcmv pentamer in complex with neutralizing antibody 9I6 | x-ray diffraction | L | — | — |
| 5VQM | Clostridium difficile tcdb-gtd bound to PA41 Fab | x-ray diffraction | L, C | — | — |
| 5W42 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin… | x-ray diffraction | L | — | — |
| 5W42 | Crystal structure of human monoclonal antibody H3V-47 in complex with influenza virus hemagglutinin… | x-ray diffraction | L | — | — |
| 5XRQ | Crystal structure of human monoclonal antibody H3V-47 | x-ray diffraction | L, B | — | — |
| 6APD | Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425 | x-ray diffraction | E, G, I | — | — |
| 6APD | Crystal structure of rsv F bound by AM22 and the infant antibody adi- 19425 | x-ray diffraction | E, G, I | — | — |
| 6ARP | Structure of a mutant cetuximab Fab fragment | x-ray diffraction | C, A | SO4 | — |
| 6ARU | Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain | x-ray diffraction | B | — | — |
| 6ARU | Structure of cetuximab Fab mutant in complex with EGFR extracellular domain | x-ray diffraction | B | — | — |
| 6BFT | Structure of bevacizumab Fab mutant in complex with VEGF | x-ray diffraction | B, L | SO4 | — |
| 6BKC | Structure of hepatitis C virus envelope glycoprotein E2 core from genotype 6A bound to broadly… | x-ray diffraction | L | — | — |
| 6DC4 | Rsv-neutralizing human antibody AM22 | x-ray diffraction | L | — | — |
| 6DC5 | Rsv prefusion F in complex with AM22 Fab | x-ray diffraction | C, F, I | — | — |
| 6DCQ | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | electron microscopy | L, N | NAG, MAN | — |
| 6E4X | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | x-ray diffraction | Y | — | 5 (best 0.55) |
| 6E4X | Human antibody S5V2-29 in complex with influenza hemagglutinin A/TEXAS/50/2012 (H3N2) | x-ray diffraction | Y | — | — |
| 6NZ7 | Crystal structure of broadly neutralizing influenza a antibody 429 B01 in complex with… | x-ray diffraction | L, I | — | — |
| 6OKQ | Crystal structure of the SF12 Fab | x-ray diffraction | B, C, E | — | — |
| 6OKQ | Crystal structure of the SF12 Fab | x-ray diffraction | B, C, E | — | — |
| 6UC5 | FAB397 in complex with npna peptide | x-ray diffraction | L | — | — |
| 7CZQ | S protein of SARS-cov-2 in complex bound with P2B-1A10 | electron microscopy | K, N | — | — |
| 7CZR | S protein of SARS-cov-2 in complex bound with P5A-1B8_2B | electron microscopy | K, N | — | — |
| 7CZS | S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B | electron microscopy | K, M, N | — | — |
| 7CZS | S protein of SARS-cov-2 in complex bound with P5A-1B8_3B | electron microscopy | K, M, N | — | — |
| 7CZU | S protein of SARS-cov-2 in complex bound with P5A-1B6_2B | electron microscopy | N, K | — | — |
| 7CZV | S protein of SARS-cov-2 in complex bound with P5A-1B6_3B | electron microscopy | K, M, N | — | — |
| 7CZX | S protein of SARS-cov-2 in complex bound with P5A-1B9 | electron microscopy | K, M, N | — | — |
1 record more on the page itself.
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.